REGENXBIO (RGNX) amends Schedule TO to update employee option exchange content
Rhea-AI Filing Summary
REGENXBIO Inc. amends its Schedule TO to report updates to an Exchange Offer that permits certain non-executive employees to exchange eligible outstanding stock options for replacement options under the terms of the company’s Offer to Exchange dated June 3, 2026. The amendment includes communications, FAQs, and plan documents; other Schedule TO disclosures remain unchanged.
Positive
- None.
Negative
- None.
Key Terms
Exchange Offer, Schedule TO, Equity Incentive Plan, Restricted Stock Unit, +1 more
5 terms
Exchange Offer financial
"offer by the Company (the “Exchange Offer”) to certain non-executive employees"
An exchange offer is a proposal where a company asks investors to swap existing securities, like bonds or shares, for new ones, often with different terms or maturity dates. It matters to investors because it can affect the value of their holdings and the company's financial strategy, potentially providing benefits like better interest rates or reduced debt.
Schedule TO regulatory
"This Amendment No. 1 to Schedule TO (together with any exhibits and annexes attached hereto"
A phrase indicating that a company plans or intends to hold an event, publish information, or take an action at a specified future time, but that the timing is not guaranteed and may change. For investors it signals an expected milestone—like an earnings call, product launch, or filing—so think of it as a calendar note rather than a firm promise; timing shifts can affect trading, expectations, and planning.
Equity Incentive Plan financial
"2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.3"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Restricted Stock Unit financial
"Form of Restricted Stock Unit Award Agreement for the 2015 Equity Incentive Plan"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Form S-8 regulatory
"Registration Statement on Form S-8 (File No. 333-288040) filed with the SEC on June 13, 2025"
A Form S-8 is a U.S. Securities and Exchange Commission registration that lets a public company set aside shares for employee benefit plans and stock-based compensation. Think of it as opening a dedicated account that authorizes the company to issue or reserve stock for workers and directors; it matters to investors because it enables share dilution when those awards are granted or exercised and signals how management is compensated and incentivized.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What is REGENXBIO's (RGNX) Exchange Offer described in the amendment?
The Exchange Offer allows certain non-executive employees to exchange eligible outstanding stock options for replacement options under the Offer to Exchange dated June 3, 2026. The amendment updates communications, FAQs, screenshots and related exhibits to the original Schedule TO.
Which employees are eligible for the option exchange in RGNX's filing?
The filing states the Exchange Offer is made to certain non-executive employees. The amendment incorporates the Offer to Exchange and related employee communications dated June 3, 2026 and July 1, 2026 for details on eligibility and terms.
What exhibits does the Schedule TO amendment attach for RGNX?
The amendment lists the Offer to Exchange, communications from the Chief People Officer, FAQs, presentation materials, screenshots of the option exchange website, and related forms and plan documents, including references to the 2015 and 2025 Equity Incentive Plans.
Does the amendment change the company’s equity plans or award agreements?
The amendment incorporates existing plan documents by reference, including the 2015 Equity Incentive Plan and the 2025 Equity Incentive Plan and their award agreement forms; it states other Schedule TO information remains unchanged except for the listed updates.
When was this Amendment No. 1 signed for REGENXBIO (RGNX)?
The signature block shows the amendment was executed by Curran Simpson, President and Chief Executive Officer, with the date July 1, 2026. The amendment supplements the Schedule TO originally filed on June 3, 2026.